miR-146a aggravates cognitive impairment and Alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling
- PMID: 37659839
- DOI: 10.1016/j.nrleng.2020.12.006
miR-146a aggravates cognitive impairment and Alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling
Abstract
Introduction: Mir-146a-5p has been widely recognized as a critical regulatory element in the immune response. However, recent studies have shown that miR-146a-5p may also be involved in the development of Alzheimer disease (AD). Regrettably, the related mechanisms are poorly understood. Here, we investigated the effects of miR-146a in mice models and SH-SY5Y cells treated with amyloid β (Aβ)1-42.
Methods: To create a model of AD, SH-SY5Y cells were treated with Aβ1-42 and mice received intracerebroventricular injections of Aβ1-42. Then, the transcriptional levels of miR-146a were estimated by real-time PCR. We transiently transfected the miR-146a-5p mimic/inhibitor into cells and mice to study the role of miR-146a. The role of signaling pathways including p38 and reactive oxygen species (ROS) was studied by using specific inhibitors. Aβ and amyloid-beta precursor protein (APP)levels were measured by immunoblotting. Furthermore, Aβ expression was analyzed by immunofluorescence and histochemical examinations.
Results: Aβ1-42-stimulated SH-SY5Y cells displayed increased transcriptional levels of miR-146a and APP. Moreover, the p38 MAPK signaling pathway and ROS production were activated upon stimulation with a miR-146a-5p mimic. However, treatment with a miR-146a-5p inhibitor decreased the levels of APP, ROS, and p-p38 MAPK. A similar phenomenon was also observed in the animals treated with Aβ1-42, in which miR-146a upregulation increased the expression of Aβ, p-p38, and ROS, while the inhibition of miR-146a had the opposite effect. This suggests that miR-146a increases Aβ deposition and ROS accumulation via the p-p38 signaling pathway.
Conclusions: Our research demonstrates that miR-146a-5pa increases Aβ deposition by triggering oxidative stress through activation of MAPK signaling.
Keywords: Alzheimer disease; Amyloid-β; Enfermedad de Alzheimer; Especies reactivas de oxígeno; MAPK signaling; Reactive oxygen species; Señalización MAPK; miR-146a-5p; β-amiloide.
Copyright © 2021 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Epigenetic transcripts of LINC01311 and hsa-miR-146a-5p regulate neural development in a cellular model of Alzheimer's disease.IUBMB Life. 2021 Jul;73(7):916-926. doi: 10.1002/iub.2472. Epub 2021 Apr 27. IUBMB Life. 2021. PMID: 33830627
-
MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.Curr Neurovasc Res. 2020;17(1):93-101. doi: 10.2174/1567202617666200128141938. Curr Neurovasc Res. 2020. PMID: 32003672
-
Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.Med Sci Monit. 2018 Aug 13;24:5635-5644. doi: 10.12659/MSM.908765. Med Sci Monit. 2018. PMID: 30102687 Free PMC article.
-
Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.Neuroscience. 2014 Oct 10;278:276-90. doi: 10.1016/j.neuroscience.2014.08.013. Epub 2014 Aug 27. Neuroscience. 2014. PMID: 25168732
-
MicroRNA-455-5p/CPEB1 pathway mediates Aβ-related learning and memory deficits in a mouse model of Alzheimer's disease.Brain Res Bull. 2021 Dec;177:282-294. doi: 10.1016/j.brainresbull.2021.10.008. Epub 2021 Oct 20. Brain Res Bull. 2021. PMID: 34678444 Review.
Cited by
-
Circulating microRNAs in Hidradenitis Suppurativa.Genes (Basel). 2022 Aug 26;13(9):1544. doi: 10.3390/genes13091544. Genes (Basel). 2022. PMID: 36140712 Free PMC article.
-
Association of MicroRNA-146a-5p Polymorphism with Cognitive Impairment in Adolescents with Depressive Disorder.Mol Syndromol. 2025 May;16(3):216-222. doi: 10.1159/000542064. Epub 2024 Nov 29. Mol Syndromol. 2025. PMID: 40475169 Free PMC article.
-
Mesenchymal Stem Cells from Familial Alzheimer's Patients Express MicroRNA Differently.Int J Mol Sci. 2024 Jan 27;25(3):1580. doi: 10.3390/ijms25031580. Int J Mol Sci. 2024. PMID: 38338859 Free PMC article.
-
Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer's Disease.Int J Mol Sci. 2024 Sep 14;25(18):9936. doi: 10.3390/ijms25189936. Int J Mol Sci. 2024. PMID: 39337429 Free PMC article. Review.
-
Recognizing Alzheimer's disease from perspective of oligodendrocytes: Phenomena or pathogenesis?CNS Neurosci Ther. 2024 Mar;30(3):e14688. doi: 10.1111/cns.14688. CNS Neurosci Ther. 2024. PMID: 38516808 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical